b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31289447</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Print">1179-1322</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>11</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cancer management and research</Title>\n                <ISOAbbreviation>Cancer Manag Res</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>5243-5254</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.2147/CMAR.S196355</ELocationID>\n            <Abstract>\n                <AbstractText><b>Background:</b> Nasopharyngeal carcinoma (NPC) is a prevalent malignant tumor in Southeast Asia. The management of NPC has remained a challenge until now. ELF-1 is a member of the ETS family of transcription factors that regulate genes involved in cellular growth. ELF-1 expression has been reported in various cancers and is required for tumor growth and angiogenesis; however, its function in NPC remains unclear. In the present study, we characterized the role and underlying mechanism of ELF-1 in NPC. <b>Methods:</b> The biological functions of ELF-1 in NPC cells such as proliferation, migration, invasion, and drug resistance were investigated using MTT, BrdU incorporation, and Transwell assays. To gain more insight into the mechanism of ELF-1 in NPC, we analyzed CCL2/CCR2 signaling by Western blotting, ELISA, siRNAs, and CCR2 antagonist. <b>Results:</b> Gain-of-function of ELF-1 in TW01 and TW04 cells promoted NPC cell proliferation, BrdU incorporation, migration, invasion and cisplatin resistance. By contrast, knockdown of ELF-1 produced opposite results. Overexpression of ELF-1 enhanced the expression of <i>CCL2</i> via binding to its promoter region and increased the level of the extracellular matrix protein CCL2 in cell culture medium. ELF-1 expression also modulated the downstream targets of CCL2/CCR2 signaling. Most importantly, ELF-1-induced NPC malignant phenotypes were abrogated by a CCR2 inhibitor, implying that the CCL2/CCR2 signaling axis was involved in ELF-1-mediated regulation in NPC. <b>Conclusion:</b> Our data suggest that ELF-1 plays an oncogenic role in NPC development associated with the CCL2/CCR2 signaling pathway and may therefore be a potential target for NPC therapy.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Chen</LastName>\n                    <ForeName>Chang-Han</ForeName>\n                    <Initials>CH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510020, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Applied Chemistry, Graduate Institute of Biomedicine and Biomedical Technology, National Chi Nan University, Nantou, 54561, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Su</LastName>\n                    <ForeName>Li-Jen</ForeName>\n                    <Initials>LJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biomedical Sciences and Engineering, College of Health Sciences and Technology, National Central University, Taoyuan City, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Education and Research Center for Technology Assisted Substance Abuse Prevention and Management, Taoyuan City, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHMed Global, Taipei City, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tsai</LastName>\n                    <ForeName>Hsin-Ting</ForeName>\n                    <Initials>HT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510020, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hwang</LastName>\n                    <ForeName>Chung-Feng</ForeName>\n                    <Initials>CF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Kaohsiung Chang Gung Head and Neck Oncology Group, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>06</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>New Zealand</Country>\n            <MedlineTA>Cancer Manag Res</MedlineTA>\n            <NlmUniqueID>101512700</NlmUniqueID>\n            <ISSNLinking>1179-1322</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">CCL2</Keyword>\n            <Keyword MajorTopicYN="N">ELF-1</Keyword>\n            <Keyword MajorTopicYN="N">NPC</Keyword>\n        </KeywordList>\n        <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31289447</ArticleId>\n            <ArticleId IdType="doi">10.2147/CMAR.S196355</ArticleId>\n            <ArticleId IdType="pii">196355</ArticleId>\n            <ArticleId IdType="pmc">PMC6560358</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Immunol. 2000 Mar 15;164(6):2857-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10706669</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Circ Res. 2001 Feb 2;88(2):237-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11157678</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunol. 2002 Nov 15;169(10):6048-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12421992</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gene. 2003 Jan 16;303:11-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12559563</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gynecol Oncol. 2003 Jun;89(3):408-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12798703</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Med. 2003 Sep;12(3):349-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12883651</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Virol. 1992 Oct;66(10):5890-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1527846</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1803-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15284088</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Cancer Drug Targets. 2004 Sep;4(6):511-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15379636</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2005 Feb 15;105(4):1405-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15498848</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2006 Apr 15;107(8):3153-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16352813</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Immunol. 2006 Feb;36(2):457-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16421945</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2006 Jun 15;107(12):4737-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16484587</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Res. 2008 Feb;6(2):259-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18314487</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Interferon Cytokine Res. 2009 Jun;29(6):313-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19441883</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2009 Dec 24;114(27):5557-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19822898</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2010 Apr 21;102(8):522-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20233997</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chin J Cancer. 2010 Apr;29(4):396-402</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20346215</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Genet. 2010 Jul;42(7):599-603</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20512145</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucleic Acids Res. 2010 Oct;38(19):6363-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20525788</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Hematol. 2010 Sep;38(9):798-8, 808.e1-2</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20600580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2011 Feb 10;117(6):1880-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21148815</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rep. 2011 Nov;26(5):1121-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21811762</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Pharmacol. 2012 Feb 1;83(3):335-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22138288</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Res. 2013 Jan;11(1):19-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23284001</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Adv Cancer Res. 2013;119:1-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23870508</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Metab Immune Disord Drug Targets. 2015;15(2):105-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25772168</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Emerg Microbes Infect. 2015 Mar;4(3):e20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26038769</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2015 Oct 10;33(29):3356-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26351355</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 May 10;7(19):28697-710</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26885690</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Cancer Res. 2016 Jan 15;6(2):141-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27186392</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2016 Oct 15;388(10054):1883-1892</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27567279</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 1989 Oct;86(20):7833-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2813360</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Transcription. 2017 May 27;8(3):193-203</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28301293</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2017 Jun;17(6):337-351</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28450705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2018 Jun 22;8(1):9575</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29934505</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Des Devel Ther. 2018 Aug 29;12:2655-2663</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30214154</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucleic Acids Res. 1993 Jul 25;21(15):3479-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8346026</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FASEB J. 1999 Feb;13(2):377-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9973326</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'